Re: Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-resistant Prostate Cancer Cell Lines

被引:6
|
作者
Luo, Jun [1 ]
Pienta, Kenneth J. [1 ]
机构
[1] Johns Hopkins Univ, Baltimore, MD 21287 USA
关键词
D O I
10.1016/j.eururo.2013.05.012
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:339 / 340
页数:3
相关论文
共 50 条
  • [21] Re: Enzalutamide in Men with Nonmetastatic, Castration-resistant Prostate Cancer
    Mason, Malcolm
    EUROPEAN UROLOGY, 2018, 74 (06) : 845 - 845
  • [22] Presence of androgen receptor splice variants in circulating tumor cells and response to cabazitaxel in castration-resistant prostate cancer
    Onstenk, W.
    Sieuwerts, A.
    Kraan, J.
    Van, M.
    Nieuweboer, A.
    Mathijssen, R.
    Hamberg, P.
    Meulenbeld, H.
    DeLaere, B.
    Dirix, L.
    Van Soest, R.
    Lolkema, M.
    Martens, J.
    Van Weerden, W.
    Jenster, G.
    Foekens, J.
    De Wit, R.
    Sleijfer, S.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S503 - S503
  • [23] Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
    Watson, Philip A.
    Chen, Yinan F.
    Balbas, Minna D.
    Wongvipat, John
    Socci, Nicholas D.
    Viale, Agnes
    Kim, Kwanghee
    Sawyers, Charles L.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (39) : 16759 - 16765
  • [24] Enzalutamide in Castration-Resistant Prostate Cancer
    Anker, Markus S.
    Lehmann, Lorenz H.
    Anker, Stefan D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (14): : 1380 - 1380
  • [25] Enzalutamide in castration-resistant prostate cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2014, 15 (08): : E312 - E312
  • [26] Androgen receptor splice variants in mouse prostate cancer cell lines: altered distribution in lines derived from castration-resistant tumors relative to those primary tumors
    Liang, Mengmeng
    Adisetiyo, Helty A.
    Li, Xiuqing
    Liu, Ren
    Gill, Parkash
    Roy-Burman, Pradip
    CANCER RESEARCH, 2013, 73 (08)
  • [27] Androgen receptor signaling dysregulates the mitotic checkpoint to mediate docetaxel resistance in castration-resistant prostate cancer
    Pilling, Amanda
    Hwang, Clara
    CANCER RESEARCH, 2020, 80 (16)
  • [28] Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants
    Mostaghel, Elahe A.
    Marck, Brett T.
    Plymate, Stephen R.
    Vessella, Robert L.
    Balk, Stephen
    Matsumoto, Alvin M.
    Nelson, Peter S.
    Montgomery, R. Bruce
    CLINICAL CANCER RESEARCH, 2011, 17 (18) : 5913 - 5925
  • [29] Androgen receptor splice variant 7 in castration-resistant prostate cancer: Clinical considerations
    Bryce, Alan H.
    Antonarakis, Emmanuel S.
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (08) : 646 - 653
  • [30] Re: Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2017, 197 (03): : 698 - 698